Vanguard Group
VMD icon

Vanguard Group’s Viemed Healthcare VMD Stock Holding History

Vanguard Group’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.2M Sell
1,782,440
-21,975
-1% -$151K ﹤0.01% 2819
2025
Q3 		$12.3M Sell
1,804,415
-15,601
-0.9% -$106K ﹤0.01% 2866
2025
Q2 		$12.6M Buy
1,820,016
+39,842
+2% +$270K ﹤0.01% 2787
2025
Q1 		$13M Sell
1,780,174
-12,061
-0.7% -$94.7K ﹤0.01% 2703
2024
Q4 		$14.4M Sell
1,792,235
-18,166
-1% -$158K ﹤0.01% 2759
2024
Q3 		$13.3M Buy
1,810,401
+30,035
+2% +$215K ﹤0.01% 2815
2024
Q2 		$11.7M Sell
1,780,366
-1,548
-0.1% -$11.7K ﹤0.01% 2830
2024
Q1 		$16.8M Buy
1,781,914
+617,009
+53% +$5.29M ﹤0.01% 2685
2023
Q4 		$9.14M Buy
1,164,905
+14,484
+1% +$105K ﹤0.01% 2996
2023
Q3 		$7.74M Buy
1,150,421
+5,546
+0.5% +$45.4K ﹤0.01% 3037
2023
Q2 		$11.2M Buy
1,144,875
+180,345
+19% +$1.83M ﹤0.01% 2875
2023
Q1 		$9.32M Sell
964,530
-10,870
-1% -$94.8K ﹤0.01% 2974
2022
Q4 		$7.37M Hold
975,400
– – ﹤0.01% 3099
2022
Q3 		$5.85M Hold
975,400
– – ﹤0.01% 3238
2022
Q2 		$5.25M Sell
975,400
-292,014
-23% -$1.57M ﹤0.01% 3360
2022
Q1 		$6.31M Buy
1,267,414
+22,148
+2% +$103K ﹤0.01% 3410
2021
Q4 		$6.5M Sell
1,245,266
-176,859
-12% -$987K ﹤0.01% 3468
2021
Q3 		$7.89M Buy
1,422,125
+192,143
+16% +$1.25M ﹤0.01% 3381
2021
Q2 		$8.79M Buy
1,229,982
+147,327
+14% +$1.28M ﹤0.01% 3275
2021
Q1 		$11M Sell
1,082,655
-188,621
-15% -$1.78M ﹤0.01% 3099
2020
Q4 		$9.87M Buy
1,271,276
+34,632
+3% +$305K ﹤0.01% 3003
2020
Q3 		$10.7M Sell
1,236,644
-13,736
-1% -$139K ﹤0.01% 2750
2020
Q2 		$12M Buy
+1,250,380
New +$9.72M ﹤0.01% 2673

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Vanguard Group's VMD Position: Q4 2025 in Review

Vanguard Group reduced its Viemed Healthcare (VMD) stake by 1.2% in Q4 2025, selling an estimated $151K and leaving 1,782,440 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2819.

Vanguard Group first reported a position in VMD in Q2 2020 and has held it in 23 quarters since. The position peaked at $16.8M in Q1 2024. 132 funds tracked by Wall St. Rank hold VMD as of Q4 2025.

  • Vanguard Group held 1,782,440 shares of Viemed Healthcare worth $13.2M as of Q4 2025.
  • Vanguard Group sold 21,975 Viemed Healthcare shares in Q4 2025, an estimated $151K.
  • Viemed Healthcare made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2819 holding.
  • Vanguard Group first reported a position in Viemed Healthcare in Q2 2020 and has held it in 23 quarters since.
  • Vanguard Group's Viemed Healthcare position peaked at $16.8M in Q1 2024.
  • 132 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.